Literature DB >> 18508510

Role of osteopontin in cellular signaling and metastatic phenotype.

Mohamed K El-Tanani1.   

Abstract

Osteopontin (opn) is a glyco-phosphoprotein that is expressed and secreted by numerous human cancers. Opn has pivotal role in cell adhesion, chemotaxis, prevention of apoptosis, invasion, migration and anchorage-independent growth of tumor cells. Extensive research has demonstrated the pivotal role of opn in regulation of cellular signaling, which controls neoplastic and malignant transformation. The elevated expression of opn has been observed in a variety of cancers. Recently, substantial evidence has linked opn with tumor metastasis and poor prognosis. However, the understanding of the molecular mechanisms that define the role of opn in cell invasion and metastasis is incomplete. The following review will discuss the molecular structure of opn, its function role in tumor cell metastasis and its downstream target genes that activate invasive mechanisms. Understanding of the role of opn in neoplastic transformation and its cellular target genes may enable development of novel anti-cancer therapy approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508510     DOI: 10.2741/3004

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  43 in total

1.  Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

Authors:  Sufen Shang; Amelie Plymoth; Shaokui Ge; Ziding Feng; Hugo R Rosen; Suleeporn Sangrajrang; Pierre Hainaut; Jorge A Marrero; Laura Beretta
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

2.  The tumor microenvironment in colorectal carcinogenesis.

Authors:  Vijay G Peddareddigari; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Microenviron       Date:  2010-03-05

3.  Cathepsin X-deficient gastric epithelial cells in co-culture with macrophages: characterization of cytokine response and migration capability after Helicobacter pylori infection.

Authors:  Anja Bernhardt; Doerthe Kuester; Albert Roessner; Thomas Reinheckel; Sabine Krueger
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

Review 4.  Recent progress in the treatment of vascular calcification.

Authors:  W Charles O'Neill; Koba A Lomashvili
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

Review 5.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

Review 6.  Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.

Authors:  Lunxiu Qin
Journal:  Front Med       Date:  2014-01-25       Impact factor: 4.592

7.  Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells.

Authors:  Dah-Yuu Lu; Wei-Lan Yeh; Ssu-Ming Huang; Chih-Hsin Tang; Hsiao-Yun Lin; Shao-Jiun Chou
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

Review 8.  Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

Authors:  Dong-Xing Cao; Zhi-Jie Li; Xiao-Ou Jiang; Yick Liang Lum; Ester Khin; Nikki P Lee; Guo-Hao Wu; John M Luk
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

9.  Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis.

Authors:  Saeedeh Salimi; Mehrangiz Noora; Sima Nabizadeh; Mahnaz Rezaei; Hossain Shahraki; Mohammadoo-Khorassani Milad; Anoosh Naghavi; Farzaneh Farajian-Mashhadi; Zahra Zakeri; Mahnaz Sandoughi
Journal:  Biomed Rep       Date:  2016-02-02

Review 10.  Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.

Authors:  Hui Liu; Licun Wu; Kai Ji; Wei Wang
Journal:  Tumour Biol       Date:  2015-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.